Telomere Therapeutics
1 known investors
Find your way into Telomere Therapeutics
Sign up to see every warm intro you have to Telomere Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Telomere Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Telomere Therapeutics is a gene therapy company developing treatments that repair telomeres to address organ fibrosis and telomere-dysfunction syndromes. Its lead program is an AAV-based therapy for idiopathic pulmonary fibrosis (IPF).
Investors · 1
Frequently asked questions
- What does Telomere Therapeutics do?
- Telomere Therapeutics is a gene therapy company developing treatments that repair telomeres to address organ fibrosis and telomere-dysfunction syndromes. Its lead program is an AAV-based therapy for idiopathic pulmonary fibrosis (IPF).
- Who are Telomere Therapeutics's investors?
- Telomere Therapeutics's investors include Invivo Capital Partners.
